Abstract:ARDS is the most frequent cause of death in intensive care medicine, yet effective pharmacological treatments are lacking. Loss of alveolar-capillary barrier function due to increased alveolar epithelial cell (AEC) apoptosis is a hallmark of ARDS and acute lung injury (ALI). We reported earlier that the Na + -coupled neutral amino acid (AA) transporter SNAT2, which transports one neutral AA along with one Na + , promotes alveolar fluid clearance by AEC-mediated Na + uptake. SNAT2s contribution to AEC homeostasis in ARDS/ALI by its role as AA transporter is, however, unknown. We hypothesize that SNAT2 is lost under inflammatory conditions, enhancing AEC apoptosis and lung permeability, thus promoting ALI. In vitro , SNAT2 was downregulated in AEC stimulated with cytomix (IFN-, TNF-α, IL-1β and LPS, 50 ng/ml) or pneumolysin (0,2 μg/ml) mimicking the inflammatory or infectious milieu of ARDS, respectively. Inhibition of SNATs by α-methylaminoisobutiric acid (MeAIB, 10mM) and specific SNAT2 knock-down in AEC increased the abundance of apoptotic cells, and the expression of pro-apoptotic CHOP compared to untreated cells. Precision-cut lung slices (PCLS) from LC3-GFP mice showed an increase in LC3-GFP + cells when stimulated with MeAIB as compared to untreated PCLS, indicating regulation of autophagy by SNAT2. In vivo , 24h after LPS-induced ALI, Slc38a2 +/- (partial SNAT2 deficient) mice had increased BALF protein content and increased CHOP expression in lung tissue compared to Slc38a2 +/+ WT mice. Our findings suggest that in ALI/ARDS, inflammation and/or infection downregulate SNAT2, promoting excessive autophagy and apoptosis of AEC, thus exacerbating ALI.

The sodium-coupled neutral amino acid transporter SNAT2 regulates alveolar epithelial cell homeostasis in acute lung injury/ARDS